Subscribe to Newsletter

Glaucoma

Business & Profession Business and Innovation

Artificial Intelligence in Ophthalmology

| Aleksandra Jones

Find out about a virtual event on AI in ophthalmology, featuring, among others, Emily Chew, Michael Chiang, Linda Zangwill, and Michael Abramoff

Subspecialties Glaucoma

My MIGS of Choice, with Ken Lin

| Ken Lin | 2 min read

When I was asked about my favorite MIGS device, it was an easy question to answer: Trabectome!

Subspecialties Basic & Translational Research

Embracing Tissue Models

| Hannah C. Lamont

Disease research should embrace the biotechnology available to increase drug development success

Business & Profession Business and Innovation

From Too Few Drops to DSLT

| Gerd Auffarth

Is there a more efficient approach to treat glaucoma patients who cannot maintain eye drop adherence?

Business & Profession Health Economics and Policy

SLT on the Front Line

| Gregor Hawlina, Matej Beltram

An expert unpacking of the SLT ascension to first line treatment for glaucoma

Subspecialties Glaucoma

Don’t Forget Your Vitamins!

| Aleksandra Jones, Jed Boye

What have glaucoma researchers Ningli Wang – in China – and Ted Garway-Heath – in the UK – been busy with?

Subspecialties Glaucoma

Recent Research Ruminations

| Ningli Wang

Despite pandemic-related challenges, my team have managed to make promising progress in glaucoma research, with a few major breakthroughs

Subspecialties Glaucoma

From the Rooftops

| Dan Lindfield

Two recent updates in the glaucoma field that are definitely worth shouting about

Subspecialties Glaucoma

Unplugging the Drain

| Hannah C. Lamont

Bringing the eye's "donut of drainage," aka trabecular meshwork and Schlemm’s canal models of glaucoma up to date with technology

Subspecialties COVID-19

Glaucoma and the Pandemic

| Aleksandra Jones

How has glaucoma care and management changed since the start of 2020?

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer element

This new disclaimer element is now part of all brands. It is editable on the start page and will be shown on all pages

Once confirmed we store a cookie to not show the disclaimer again.